Skip navigation
Home
Browse
Communities
& Collections
Browse Items by:
Issue Date
Author
Title
Subject
Help
Sign on to:
My DSpace
Receive email
updates
Edit Profile
Mahidol University's Institutional Repository (Mahidol IR)
Simple jQuery Dropdowns
About Us
Ethics
Service
Statistics & Reports
Feedback
Browsing by Author James J. Vredenburgh
Jump to:
0-9
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or enter first few letters:
Sort by:
title
issue date
submit date
In order:
Ascending
Descending
Results/Page
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Authors/Record:
All
1
5
10
15
20
25
30
35
40
45
50
Showing results 1 to 5 of 5
Issue Date
Title
Author(s)
1-Mar-2012
Outcome after bevacizumab clinical trial therapy among recurrent grade III malignant glioma patients
David A. Reardon
;
James E. Herndon
;
Katherine Peters
;
Annick Desjardins
;
April Coan
;
Emil Lou
;
Ashley Sumrall
;
Scott Turner
;
Sith Sathornsumetee
;
Jeremy N. Rich
;
Susan Boulton
;
Eric S. Lipp
;
Henry S. Friedman
;
James J. Vredenburgh
;
Dana-Farber Cancer Institute
;
Duke University School of Medicine
;
Mahidol University
;
Cleveland Clinic Foundation
1-Jul-2012
Phase 1 trial of dasatinib plus erlotinib in adults with recurrent malignant glioma
David A. Reardon
;
James J. Vredenburgh
;
Annick Desjardins
;
Katherine B. Peters
;
Sith Sathornsumetee
;
Stevie Threatt
;
John H. Sampson
;
James E. Herndon
;
April Coan
;
Frances McSherry
;
Jeremy N. Rich
;
Roger E. McLendon
;
Steven Zhang
;
Henry S. Friedman
;
Dana-Farber Cancer Institute
;
Duke University School of Medicine
;
Mahidol University
;
Cleveland Clinic Foundation
;
Bristol-Myers Squibb
1-Dec-2011
Phase i study of sunitinib and irinotecan for patients with recurrent malignant glioma
David A. Reardon
;
James J. Vredenburgh
;
April Coan
;
Annick Desjardins
;
Katherine B. Peters
;
Sridharan Gururangan
;
Sith Sathornsumetee
;
Jeremy N. Rich
;
James E. Herndon
;
Henry S. Friedman
;
Duke University School of Medicine
;
Mahidol University
;
Cleveland Clinic Foundation
1-Oct-2012
Phase II study of Gleevec plus hydroxyurea in adults with progressive or recurrent low-grade glioma
David A. Reardon
;
Annick Desjardins
;
James J. Vredenburgh
;
James E. Herndon
;
April Coan
;
Sridharan Gururangan
;
Katherine B. Peters
;
Roger McLendon
;
Sith Sathornsumetee
;
Jeremy N. Rich
;
Eric S. Lipp
;
Dorothea Janney
;
Henry S. Friedman
;
Duke University
;
Mahidol University
;
Cleveland Clinic Foundation
1-Dec-2010
Phase II trial of bevacizumab and erlotinib in patients with recurrent malignant glioma
Sith Sathornsumetee
;
Annick Desjardins
;
James J. Vredenburgh
;
Roger E. McLendon
;
Jennifer Marcello
;
James E. Herndon
;
Alyssa Mathe
;
Marta Hamilton
;
Jeremy N. Rich
;
Julie A. Norfleet
;
Sridharan Gururangan
;
Henry S. Friedman
;
David A. Reardon
;
Duke University School of Medicine
;
Cleveland Clinic Foundation
;
Mahidol University
;
OSI Pharmaceuticals Inc.